nodes	percent_of_prediction	percent_of_DWPC	metapath
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0518	0.0518	CbGpPWpGaD
Nadolol—ADRB3—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0441	0.0441	CbGpPWpGaD
Nadolol—ADRB3—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0428	0.0428	CbGpPWpGaD
Nadolol—ADRB3—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0399	0.0399	CbGpPWpGaD
Nadolol—ADRB3—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0371	0.0371	CbGpPWpGaD
Nadolol—ADRB3—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.036	0.036	CbGpPWpGaD
Nadolol—ADRB3—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0336	0.0336	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0307	0.0307	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.03	0.03	CbGpPWpGaD
Nadolol—ADRB3—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.028	0.028	CbGpPWpGaD
Nadolol—ADRB1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0262	0.0262	CbGpPWpGaD
Nadolol—ADRB2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0256	0.0256	CbGpPWpGaD
Nadolol—ADRB1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0254	0.0254	CbGpPWpGaD
Nadolol—ADRB2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0249	0.0249	CbGpPWpGaD
Nadolol—ADRB1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0237	0.0237	CbGpPWpGaD
Nadolol—ADRB3—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0235	0.0235	CbGpPWpGaD
Nadolol—ADRB2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0232	0.0232	CbGpPWpGaD
Nadolol—ADRB1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.022	0.022	CbGpPWpGaD
Nadolol—ADRB2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0215	0.0215	CbGpPWpGaD
Nadolol—ADRB1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0214	0.0214	CbGpPWpGaD
Nadolol—ADRB2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0209	0.0209	CbGpPWpGaD
Nadolol—ADRB1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0199	0.0199	CbGpPWpGaD
Nadolol—ADRB2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0195	0.0195	CbGpPWpGaD
Nadolol—ADRB1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0166	0.0166	CbGpPWpGaD
Nadolol—ADRB2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0162	0.0162	CbGpPWpGaD
Nadolol—ADRB1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0139	0.0139	CbGpPWpGaD
Nadolol—ADRB2—Arf6 signaling events—MET—Gilles de la Tourette syndrome	0.0138	0.0138	CbGpPWpGaD
Nadolol—ADRB2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0136	0.0136	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.0114	0.0114	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.0111	0.0111	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00852	0.00852	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00827	0.00827	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.0077	0.0077	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0073	0.0073	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00721	0.00721	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00708	0.00708	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.0066	0.0066	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00556	0.00556	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00539	0.00539	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00539	0.00539	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00506	0.00506	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00503	0.00503	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00495	0.00495	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00491	0.00491	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.0048	0.0048	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00462	0.00462	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00457	0.00457	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00447	0.00447	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00433	0.00433	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00424	0.00424	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0042	0.0042	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00411	0.00411	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00392	0.00392	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00383	0.00383	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00352	0.00352	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0033	0.0033	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00323	0.00323	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0032	0.0032	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0032	0.0032	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00314	0.00314	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00313	0.00313	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00313	0.00313	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00305	0.00305	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00298	0.00298	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00292	0.00292	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00285	0.00285	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00284	0.00284	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00277	0.00277	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00274	0.00274	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00268	0.00268	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00258	0.00258	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00209	0.00209	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00204	0.00204	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00199	0.00199	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00186	0.00186	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00182	0.00182	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00181	0.00181	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00181	0.00181	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00177	0.00177	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00169	0.00169	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00169	0.00169	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00168	0.00168	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00166	0.00166	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00165	0.00165	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00164	0.00164	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00164	0.00164	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00164	0.00164	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00161	0.00161	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00153	0.00153	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00152	0.00152	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.0015	0.0015	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00122	0.00122	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00118	0.00118	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00115	0.00115	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00107	0.00107	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00107	0.00107	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00105	0.00105	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.001	0.001	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000978	0.000978	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000971	0.000971	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00095	0.00095	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000904	0.000904	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000885	0.000885	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000633	0.000633	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00062	0.00062	CbGpPWpGaD
